Decision Quality Return on Investment

Pharma Industry Decision Quality ROI

  • img
    Click to enlarge
  • During the seven years of portfolio DA adoption across the Pharmaceutical Industry, we tracked the Adopters Index against the DJ Pharma Index and the much broader S&P 500 Index.

    "In the end we learned that our portfolio was worth $2.6 billion more than it was when we started. This was powerful confirmation that our efforts were worthwhile."

    • – Paul Sharpe, VP SmithKline Beecham
      (now GlaxoSmithkline)

    "I estimate the extra cost to SB for this effort was $2 Million.
    So the payoff was 1300 to 1. "

    • – Tom Keelin